Posterior Capsule Opacification Clinical Trial
Official title:
Objective Refraction Changes After Using ND: YAG LASER In Treatment of Posterior Capsular Opacification In Pseudo Phakic Eye After Successful Non Complicated Cataract Surgery
The most prevalent long term consequence of cataract surgery in both phacoemulsification and extracapsular cataract excision is posterior capsular opacification (PCO) PCO occurred in 11.8 percent of patients one year after surgery, 20.7 percent in three years, and 28.4 percent in five years . It causes lower visual acuity, decreased contrast sensitivity, stereoscopic vision, increases glare and monocular diplopia. The pathogenesis of PCO is dependent on the growth of lens epithelial cell remnants in the intracapsular region. Continuous curvilinear capsulorhexis, good hydro dissection, efficient removal of cortical and lenticular epithelial cells, in-the-bag IOL implantation, and the use of single-piece acrylic sharp edges IOLs are all factors in PCO avoidance. Intraoperatively, anti-metabolites such as 5-fluorouracil and mitomycin C may also be utilized. Fortunately, the overall prevalence of PCO and the using of neodymium-yttrium-aluminum-garnet (Nd: YAG) laser posterior Capsulotomy rates have dropped from 50% to fewer than 10% now The standard therapy for PCO is now Nd: YAG laser posterior capsulotomy, which has a success rate of more than 95%. The neodymium: yttrium-aluminum-garnet (Nd:YAG) laser, with a wavelength of 1064 nm, is a solid-state laser that may destroy ocular tissues by achieving optical breakdown with a brief, high-power pulse .Ionization or plasma production occurs in the ocular tissue as a result of optical breakdown. This plasma production subsequently generates acoustic and shock waves, which destroy tissue. Because of its cost-effectiveness, speed, and lack of invasiveness, it is the chosen treatment option in PCO. However laser capsulotomy is not free of complications including transient intraocular pressure (IOP) elevation, hyphema, uveitis, cystoid macular edema, and retinal detachments that occur most frequently in the first few months . Apart from the afore mentioned biological complications, mechanical effects of laser capsulotomy such as pitting of IOL, dislocation of IOL into the vitreous, and shift in the position of IOL have also be reported Displacement of the IOL following laser capsulotomy, which may be impacted by the capsulotomy size , might hypothetically modify the effective power of the IOL as well as the patients' refractive state may be altered . However, with the exception of one research that demonstrated a hyperopic shift after Nd:YAG laser capsulotomy , most prior investigations failed to show a significant change in refraction before and after Nd:YAG laser capsulotomy . According to earlier study , the size and form of Nd:YAG laser capsulotomy, the energy utilized in Nd:YAG laser capsulotomy, and the designs of IOL did not alter the post-laser refractive state. It is still unknown if the time of laser capsulotomy affects the refractive and visual prognosis of patients after Nd:YAG laser capsulotomy. Because the IOL would continue to rotate for at least 6 months following cataract surgery, Any considerable change in IOL position might result in a change in the patient's refractive state, necessitating corrective lens prescriptions
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06060041 -
IC-8 Apthera IOL New Enrollment Post Approval Study
|
||
Completed |
NCT03321253 -
Changes of Macular Pigment and Parameters of Eyes After YAG Laser Treatment in Cases With Capsule Opacification
|
N/A | |
Recruiting |
NCT03701139 -
Posterior Capsulotomy in Cataract Complicated With Primary Posterior Capsule Opacification.
|
N/A | |
Completed |
NCT03184428 -
Posterior Capsule Opacification Following Cataract Surgery With Implantation of the MICS IOL L313
|
||
Recruiting |
NCT02445274 -
Two Different Cataract Surgical Procedures to Prevent Posterior Capsule Opacification
|
N/A | |
Completed |
NCT02968290 -
Quantification of Posterior Capsule Opacification in Pediatric Cataract
|
N/A | |
Completed |
NCT01936701 -
Comparison of the Effect of Hydrophobic Acrylic and Silicone 3-piece IOLs on Posterior Capsule Opacification
|
N/A | |
Completed |
NCT01786356 -
Posterior Capsule Opacification and Frequency of Nd:YAG Treatment and of Two IOLs: Hoya iMics Y-60H vs. Bausch&Lomb MI60 (MIMI)
|
N/A | |
Completed |
NCT03192826 -
Brinzolamide/Brimonidine Combination vs Brimonidine 0.2% in the Prevention of IOP Rise After Nd-YAG Laser Capsulotomy
|
Phase 4 | |
Completed |
NCT00855491 -
Posterior Capsule Opacification (PCO) With AcrySof Single-Piece IOL
|
N/A | |
Completed |
NCT03831074 -
Posterior Capsule Opacification and Optical Quality of Different Hydrophobic Acrylic Intraocular Lenses
|
N/A | |
Completed |
NCT01734343 -
Posterior Capsule Opacification Development With Two Different Intraocular Lenses
|
N/A | |
Completed |
NCT01125345 -
Posterior Capsule Opacification (PCO) With Single Piece Hydrophobic Versus Hydrophillic Intraocular Lens (IOL)
|
Phase 4 | |
Recruiting |
NCT03857685 -
LEC Proliferation in Vivo and In-vitro
|
||
Active, not recruiting |
NCT03605160 -
An Innovative Method Fluid-jet to to Remove Residual Lens Fibers
|
N/A | |
Completed |
NCT04007965 -
Novel Technique of Pneumatic Posterior Capsulorhexis for Treatment and Prevention of Posterior Capsular Opacification
|
N/A | |
Recruiting |
NCT03857412 -
Posterior Capsule Opacification After Lens Capsule Polishing
|
N/A | |
Completed |
NCT02975895 -
Outcome of Different IOLs in Patients With and Without Uveitis
|
N/A | |
Completed |
NCT02491918 -
Clinical Trial : Complications of in the Bag IOL Versus Optic Capture of IOL in Pediatric Cataract Surgery
|
N/A | |
Recruiting |
NCT06083025 -
Influence of CleaRing Open-capsule Device on Refractive Predictability in Cataract Patients (Part 2)
|
N/A |